Predicting drug approvals: The Novartis data science and artificial intelligence challenge

Predicting drug approvals: The Novartis data science and artificial intelligence challenge

We describe a novel collaboration between academia and industry, an in-house data science and artificial intelligence challenge held by Novartis to develop machine-learning models for predicting drug-development outcomes, building upon research at MIT using data from Informa as the starting point. W...

Full description

Bibliographic Details
Main Authors: Siah, Kien Wei, Kelley, Nicholas W, Ballerstedt, Steffen, Holzhauer, Björn, Lyu, Tianmeng, Mettler, David, Sun, Sophie, Wandel, Simon, Zhong, Yang, Zhou, Bin, Pan, Shifeng, Zhou, Yingyao, Lo, Andrew W
Other Authors: Sloan School of Management. Laboratory for Financial Engineering
Format: Article
Language:English
Published: Elsevier BV 2022
Online Access:https://hdl.handle.net/1721.1/144207

Internet

https://hdl.handle.net/1721.1/144207

Similar Items